Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Adjuvanted and New Formulation Hepatitis B Vaccines vs Engerix-B
NCT00697840Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 1995
- Primary completion
- Jan 1996
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Jun 1995; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697840.